Clinical Trial Update: A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Azenosertib (ZN-c3) in patients with epithelial ovarian cancer and other solid tumors is currently recruiting. The sponsor i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Azenosertib (ZN-c3) (azenosertib)

Snippet

Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | Conditions: Solid Tumor, Epithelial Ovarian Cancer | Phase 1 | Status: RECRUITING